Literature DB >> 16881035

Antibacterial natural products in medicinal chemistry--exodus or revival?

Franz von Nussbaum1, Michael Brands, Berthold Hinzen, Stefan Weigand, Dieter Häbich.   

Abstract

To create a drug, nature's blueprints often have to be improved through semisynthesis or total synthesis (chemical postevolution). Selected contributions from industrial and academic groups highlight the arduous but rewarding path from natural products to drugs. Principle modification types for natural products are discussed herein, such as decoration, substitution, and degradation. The biological, chemical, and socioeconomic environments of antibacterial research are dealt with in context. Natural products, many from soil organisms, have provided the majority of lead structures for marketed anti-infectives. Surprisingly, numerous "old" classes of antibacterial natural products have never been intensively explored by medicinal chemists. Nevertheless, research on antibacterial natural products is flagging. Apparently, the "old fashioned" natural products no longer fit into modern drug discovery. The handling of natural products is cumbersome, requiring nonstandardized workflows and extended timelines. Revisiting natural products with modern chemistry and target-finding tools from biology (reversed genomics) is one option for their revival.

Mesh:

Substances:

Year:  2006        PMID: 16881035     DOI: 10.1002/anie.200600350

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  88 in total

1.  Initial efforts toward the optimization of arylomycins for antibiotic activity.

Authors:  Tucker C Roberts; Mark A Schallenberger; Jian Liu; Peter A Smith; Floyd E Romesberg
Journal:  J Med Chem       Date:  2011-06-28       Impact factor: 7.446

2.  Motualevic acids and analogs: synthesis and antimicrobial structure-activity relationships.

Authors:  Pradeep Cheruku; Jessica L Keffer; Cajetan Dogo-Isonagie; Carole A Bewley
Journal:  Bioorg Med Chem Lett       Date:  2010-06-09       Impact factor: 2.823

3.  Staphylococcus aureus TargetArray: comprehensive differential essential gene expression as a mechanistic tool to profile antibacterials.

Authors:  H Howard Xu; John D Trawick; Robert J Haselbeck; R Allyn Forsyth; Robert T Yamamoto; Rich Archer; Joe Patterson; Molly Allen; Jamie M Froelich; Ian Taylor; Danny Nakaji; Randy Maile; G C Kedar; Marshall Pilcher; Vickie Brown-Driver; Melissa McCarthy; Amy Files; David Robbins; Paula King; Susan Sillaots; Cheryl Malone; Carlos S Zamudio; Terry Roemer; Liangsu Wang; Philip J Youngman; Daniel Wall
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

4.  Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules.

Authors:  Warren R J D Galloway; Albert Isidro-Llobet; David R Spring
Journal:  Nat Commun       Date:  2010-09-21       Impact factor: 14.919

5.  Broad-spectrum antibiotic activity of the arylomycin natural products is masked by natural target mutations.

Authors:  Peter A Smith; Tucker C Roberts; Floyd E Romesberg
Journal:  Chem Biol       Date:  2010-11-24

Review 6.  Molecular basis and phenotype of methicillin resistance in Staphylococcus aureus and insights into new beta-lactams that meet the challenge.

Authors:  Leticia I Llarrull; Jed F Fisher; Shahriar Mobashery
Journal:  Antimicrob Agents Chemother       Date:  2009-05-26       Impact factor: 5.191

7.  Enantioselective synthesis of pactamycin, a complex antitumor antibiotic.

Authors:  Justin T Malinowski; Robert J Sharpe; Jeffrey S Johnson
Journal:  Science       Date:  2013-04-12       Impact factor: 47.728

8.  Synthesis of 9-Dechlorochrysophaentin A Enables Studies Revealing Bacterial Cell Wall Biosynthesis Inhibition Phenotype in B. subtilis.

Authors:  Christopher R Fullenkamp; Yen-Pang Hsu; Ellen M Quardokus; Gengxiang Zhao; Carole A Bewley; Michael VanNieuwenhze; Gary A Sulikowski
Journal:  J Am Chem Soc       Date:  2020-09-08       Impact factor: 15.419

9.  The marinopyrroles, antibiotics of an unprecedented structure class from a marine Streptomyces sp.

Authors:  Chambers C Hughes; Alejandra Prieto-Davo; Paul R Jensen; William Fenical
Journal:  Org Lett       Date:  2008-01-19       Impact factor: 6.005

10.  Allosteric control of the ribosome by small-molecule antibiotics.

Authors:  Leyi Wang; Arto Pulk; Michael R Wasserman; Michael B Feldman; Roger B Altman; Jamie H Doudna Cate; Scott C Blanchard
Journal:  Nat Struct Mol Biol       Date:  2012-08-19       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.